Susquehanna International Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100,000
Closed -$21.7M 13695
2021
Q1
$21.7M Sell
100,000
-158,000
-61% -$29.7M ﹤0.01% 1781
2020
Q4
$29.8M Sell
258,000
-7,900
-3% -$885K ﹤0.01% 1382
2020
Q3
$25.9M Buy
265,900
+79,500
+43% +$9.15M 0.01% 1271
2020
Q2
$22.9M Sell
186,400
-86,300
-32% -$9.79M 0.01% 1318
2020
Q1
$23.9M Sell
272,700
-265,400
-49% -$28.1M 0.01% 1068
2019
Q4
$56.3M Buy
538,100
+88,100
+20% +$9.88M 0.02% 743
2019
Q3
$51.8M Buy
450,000
+111,400
+33% +$16.9M 0.02% 719
2019
Q2
$58.4M Sell
338,600
-12,800
-4% -$2.21M 0.02% 614
2019
Q1
$59.2M Sell
351,400
-98,200
-22% -$14.6M 0.02% 539
2018
Q4
$43.8M Buy
449,600
+31,700
+8% +$4.16M 0.02% 658
2018
Q3
$72.2M Sell
417,900
-37,200
-8% -$5.36M 0.02% 541
2018
Q2
$63.5M Sell
455,100
-12,900
-3% -$1.83M 0.02% 583
2018
Q1
$52.7M Buy
468,000
+242,600
+108% +$30.5M 0.02% 639
2017
Q4
$29.8M Sell
225,400
-46,000
-17% -$5.4M 0.01% 989
2017
Q3
$27.5M Buy
271,400
+4,100
+2% +$439K 0.01% 1008
2017
Q2
$26.8M Sell
267,300
-142,100
-35% -$15.3M 0.01% 942
2017
Q1
$49.5M Sell
409,400
-211,900
-34% -$26M 0.03% 577
2016
Q4
$69.4M Buy
621,300
+144,300
+30% +$17.4M 0.04% 439
2016
Q3
$63.3M Buy
477,000
+220,700
+86% +$21.1M 0.03% 455
2016
Q2
$23.5M Buy
256,300
+4,400
+2% +$370K 0.01% 876
2016
Q1
$18.2M Sell
251,900
-222,600
-47% -$12.2M 0.01% 1062
2015
Q4
$32.9M Buy
474,500
+190,600
+67% +$15.5M 0.02% 821
2015
Q3
$25.9M Buy
283,900
+76,700
+37% +$8.53M 0.01% 1010
2015
Q2
$25.5M Buy
207,200
+79,700
+63% +$9.04M 0.01% 1104
2015
Q1
$11.6M Sell
127,500
-111,800
-47% -$9.08M 0.01% 1723
2014
Q4
$16.2M Sell
239,300
-187,100
-44% -$13.7M 0.01% 1525
2014
Q3
$34.5M Buy
426,400
+47,500
+13% +$4.2M 0.01% 976
2014
Q2
$40.7M Buy
+378,900
New +$26.3M 0.02% 839

Other funds holding GWPH

Susquehanna International Group's GWPH Position: Q2 2021 in Review

Susquehanna International Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 3,617 shares — an estimated $785K sold.

Susquehanna International Group first reported a position in GWPH in Q1 2014 and held it in 26 quarters. The position peaked at $34.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Susquehanna International Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Susquehanna International Group sold 3,617 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $785K.
  • Susquehanna International Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 26 quarters.
  • Susquehanna International Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $34.2M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.